The Inflammation Resolution Stack: Curcumin + Boswellia + SPMs

Open a typical anti-inflammatory stack and you find curcumin, quercetin, resveratrol, and green tea extract — four polyphenols converging on roughly the same signalling node, bought four times. Adding more of the same mechanism is not a stack. It is a redundancy.

This one is assembled differently: four layers, each doing something the others cannot.

Layer 1 — Omega-3: The Base Nobody Should Skip

Two grams a day of combined EPA and DHA is the cheapest and best-evidenced item here, and it is a precondition rather than an addition. Every resolvin, protectin, and maresin is enzymatically derived from EPA or DHA. ^[8] A resolution-focused stack built on a depleted omega-3 base is missing its substrate.

Read the EPA+DHA content, not the capsule weight — a "1000 mg fish oil" softgel commonly contains 300 mg of actual omega-3.

Layer 2 — Curcumin: Suppression, If You Choose the Right Form

Curcumin is the most-studied compound in the category, and the evidence for what it does is reasonable: an updated meta-analysis of randomised trials found it lowers C-reactive protein, ^[1] and a meta-analysis of arthritis trials found symptom relief, in several cases comparable to standard analgesics. ^[2]

The complication is absorption. Plain curcumin is poorly soluble and rapidly conjugated, and a comparative human study found formulations differ by more than an order of magnitude at equal curcuminoid content. ^[3] The milligram figure on the front of the bottle is close to uninformative on its own.

Piperine solves the problem by inhibiting the clearance enzymes — it raised bioavailability around 2000% in the classic human study ^[4] — but those same enzymes (CYP3A4, glucuronidation) metabolise many prescription drugs. Phytosome or micellar delivery achieves the same goal without the interaction, which is why it is the default recommendation here.

Dose: 1000 mg curcuminoids/day, split, with a fat-containing meal.

Layer 3 — Boswellia: The Branch Nothing Else Covers

Arachidonic acid leaves the membrane and takes one of two roads: cyclooxygenase to prostaglandins, or 5-lipoxygenase to leukotrienes. NSAIDs work on the first road. So, largely, does curcumin. The leukotriene branch is left alone by almost everything in an ordinary supplement cabinet.

Boswellia is the exception. Boswellic acids — chiefly AKBA — inhibit 5-LOX, and also interfere with microsomal prostaglandin E synthase-1 and cathepsin G. ^[5] That is the mechanistic justification for combining it with curcumin rather than choosing between them.

The clinical evidence sits in knee osteoarthritis: a systematic review and meta-analysis of Boswellia oleogum resin extracts found improvements in pain and function, ^[6] and a network meta-analysis went further, comparing Curcuma longa, Boswellia serrata, and mixed formulations directly. ^[7]

Standardisation is where products diverge. "400 mg Boswellia extract" means nothing on its own; "65% boswellic acids" is the usual baseline and an explicit AKBA percentage is better. Target 100–250 mg/day of an AKBA-enriched extract, or 300–400 mg two to three times daily of a 65% extract.

Layer 4 — SPMs: Real Biology, Early Evidence

Resolution is an active programme rather than passive fading, and SPMs are its signalling molecules — halting neutrophil recruitment and driving macrophage clearance of debris without suppressing immunity, which is precisely what NSAIDs and steroids cannot do. ^[8]

A randomised, double-blind, placebo-controlled study found that enriched marine oil supplements raise peripheral blood SPM concentrations and reprogram host immune responses. ^[9] The biomarker effect in humans is established.

What is not established is the outcome layer: trials showing that raising SPM levels improves defined clinical endpoints. That is why SPMs are the last layer, used in defined blocks — around an injury, a heavy training phase, a flare — rather than indefinitely, and why they belong on top of adequate omega-3 rather than instead of it.

The Build Order

Add one layer every four weeks, so that any change is attributable.

1. Weeks 1–4: omega-3, 2 g EPA+DHA.
2. Weeks 5–8: add curcumin 1000 mg, phytosome or micellar.
3. Weeks 9–12: add boswellia if joints are the primary complaint — that is where its data are.
4. Optional, in blocks: SPMs at 1000 mg during recovery or flare periods.
5. Measure at 12 weeks: hs-CRP plus your own symptom notes. If you did not record a baseline, you cannot evaluate the experiment.

Step-by-step timing and contraindications are in the inflammation resolution protocol.

Safety, Concretely

• Curcumin: liver injury from turmeric and curcuminoid supplements is rare but documented, and reports cluster around high-bioavailability and piperine-enhanced products rather than culinary turmeric. ^[10] Investigate jaundice, dark urine, or unexplained fatigue rather than pushing through. Stop two weeks before surgery; avoid with gallstones; expect reduced non-haem iron absorption.
• Boswellia: avoid in pregnancy; otherwise well tolerated.
• Omega-3 and SPMs: additive bleeding risk with warfarin, DOACs, and antiplatelet drugs — tell your prescriber rather than assuming supplements do not count.
• Diagnosed inflammatory disease — rheumatoid arthritis, IBD, psoriasis — has disease-modifying therapy that works. This stack is a supporting layer there, never a substitute.

What Actually Moves Inflammatory Markers

The uncomfortable proportionality: visceral fat, sleep debt, smoking, periodontal disease, sedentary behaviour, and untreated insulin resistance raise inflammatory markers more than this stack lowers them. A single night of curtailed sleep measurably increases inflammatory signalling.

Supplements are the last ten percent of this problem. Taking them while sleeping five hours a night is paying for a mechanism you are actively overwhelming.

The One-Line Version

Stack by mechanism, not by ingredient count: substrate, suppression, the leukotriene branch, and resolution. Choose curcumin by formulation and boswellia by AKBA standardisation, keep SPMs as a targeted block rather than a daily default, and fix sleep and body composition before expecting any of it to show up in hs-CRP.

Related Reading

• Curcumin Bioavailability: Why Form Matters More Than Dose
• Specialized Pro-Resolving Mediators: Beyond Omega-3
• The Liver Optimization Protocol